Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 4, 2012, Pages 1027-1038

  Pardon, Bart ^a   Catry, Boudewijn ^b   Dewulf, Jeroen ^a   Persoons, Davy ^a   Hostens, Miel ^a   De bleecker, Koen ^c   Deprez, Piet ^a  

^a GHENT UNIVERSITY   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c ANIMAL HEALTH CARE FLANDERS   (Belgium)

Author keywords

Anti inflammatory drugs; Antimicrobials; Defined daily doses; Dosing; Group treatment

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CEFQUINOME; CEFTIOFUR; COLISTIN; DANOFLOXACIN; DIFLOXACIN; DIHYDROSTREPTOMYCIN; DOXYCYCLINE; ENROFLOXACIN; FLORFENICOL; FLUMEQUINE; GENTAMICIN; MARBOFLOXACIN; NEOMYCIN; OXYTETRACYCLINE; PAROMOMYCIN; PROCAINE PENICILLIN; SULFONAMIDE; TILMICOSIN; TRIMETHOPRIM; TULATHROMYCIN; TYLOSIN;

ARTICLE; BELGIUM; CATTLE; DRUG USE; NONHUMAN; PROPHYLAXIS; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK FACTOR; WHITE VEAL CALF;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BELGIUM; CATTLE; CATTLE DISEASES; DRUG UTILIZATION; PROSPECTIVE STUDIES;

EID: 84858689009     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr570     Document Type: Article

References (54)

1. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64 Suppl 1: i3-10.
2. Catry B, Decostere A, Schwarz S et al. Detection of tetracyclineresistant and susceptible Pasteurellaceae in the nasopharynx of loose group-housed calves. Vet Res Commun 2006; 30: 707-15.
3. Catry B, Dewulf J, Goffin T et al. Antimicrobial resistance patterns of Escherichia coli through the digestive tract of veal calves. Microb Drug Resist 2007; 13: 147-50.
4. Catry B, Haesebrouck F, Vliegher SD et al. Variability in acquired resistance of Pasteurella and Mannheimia isolates from the nasopharynx of calves, with particular reference to different herd types. Microb Drug Resist 2005; 11: 387-94.
5. Di Labio E, Regula G, Steiner A et al. Antimicrobial resistance in bacteria from Swiss veal calves at slaughter. Zoonoses Public Health 2007; 54: 344-52.
6. Hendriksen RS, Mevius DJ, Schroeter A et al. Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002-2004: the ARBAO-II study. Acta Vet Scand 2008; 50: 19.
7. Hendriksen RS, Mevius DJ, Schroeter A et al. Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002-2004. Acta Vet Scand 2008; 50: 28.
8. Persoons D, Dewulf J, Smet A et al. Prevalence and persistence of antimicrobial resistance in broiler indicator bacteria. Microb Drug Resist 2010; 16: 67-74.
9. Timmerman T, Dewulf J, Catry B et al. Quantification and evaluation of antimicrobial drug use in group treatments for fattening pigs in Belgium. Prev Vet Med 2006; 74: 251-63.
10. Persoons D, Dewulf J, Smet A et al. Antimicrobial use in Belgian broiler production and influencing factors. In: Persoons D, Antimicrobial use and resistance in Belgian broiler production. PhD Thesis. Ghent University, 2011. ISBN 978-90-5864-246-2.
11. Vanderhaeghen W, Hermans K, Haesebrouck F et al. Methicillinresistant Staphylococcus aureus (MRSA) in food production animals. Epidemiol Infect 2010; 138: 606-25.
12. Johnson AP. Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 2011; 66 Suppl 4: iv43-8.
13. Philips I, Casewell M, Cox T et al. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 2004; 53: 28-52.
14. Tenover FC, McGowan JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996; 311: 9-16.
15. Berge AC, Moore DA, Sischo WM. Field trial evaluating the influence of prophylactic and therapeutic antimicrobial administration on antimicrobial resistance of fecal Escherichia coli in dairy calves. Appl Environ Microbiol 2006; 72: 3872-8.
16. Donaldson SC, Straley BA, Hegde NV et al. Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves. Appl Environ Microbiol 2006; 72: 3940-8.
17. Jensen VF, Jakobsen L, Emborg HD et al. Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicinresistant Escherichia coli. J Antimicrob Chemother 2006; 58: 101-7.
18. Checkley SL, Campbell JR, Chirino-Trejo M et al. Associations between antimicrobial use and the prevalence of antimicrobial resistance in fecal Escherichia coli from feedlot cattle in western Canada. Can Vet J 2010; 51: 853-61.
19. David MD, Gill MJ. Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin. J Antimicrob Chemother 2008; 61: 962-4.
20. Gonzalez SM, Steiner A, Gassner B et al. Antimicrobial use in Swiss dairy farms: quantification and evaluation of data quality. Prev Vet Med 2010; 95: 50-63.
21. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATCvet Classification and DDD Assignment. 2002. http://www.whocc.no/atcvet (17 September 2011, date last accessed).
22. Grave K, Kaldhusdal MC, Kruse H et al. What has happened in Norway after the ban of avoparcin? Consumption of antimicrobials by poultry. Prev Vet Med 2004; 62: 59-72.
23. Grave K, Greko C, Nilsson L et al. The usage of veterinary antibacterial drugs for mastitis in cattle in Norway and Sweden during 1990-1997. Prev Vet Med 1999; 42: 45-55.
24. Pol M, Ruegg PL. Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin. J Dairy Sci 2007; 90: 249-61.
25. Gow SP, Waldner CL. Antimicrobial drug use and reason for treatment in 203 western Canadian cow-calf herds during calving season. Prev Vet Med 2009; 90: 55-65.
26. Vieira AR, Pires SM, Houe H et al. Trends in slaughter pig production and antimicrobial consumption in Danish slaughter pig herds, 2002-2008. Epidemiol Infect 2011; 139: 1601-9.
27. Graveland H, Wagenaar JA, Heesterbeek H et al. Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS ONE 2010; 5: e10990.
28. Smith GW, Davis JL, Tell LA et al. Extralabel use of nonsteroidal anti-inflammatory drugs in cattle. J Am Vet Med Assoc 2008; 232: 697-701.
29. Aarestrup FM. Veterinary drug usage and antimicrobial resistance in bacteria of animal origin. Basic Clin Pharmacol 2005; 96: 271-81.
30. Chauvin C, Madec F, Guillemot D et al. The crucial question of standardisation when measuring drug consumption. Vet Res 2001; 32: 533-43.
31. Jensen VF, Jacobsen E, Bager F. Veterinary antimicrobial-usage statistics based on standardized measures of dosage. Prev Vet Med 2004; 64: 201-15.
32. Belgian Pharmaceutical Industry Organization. Belgian Compendium on Veterinary Medicines. Oostende: Goekint, 2009.
33. Dumartin C, L'Heriteau F, Pefau M et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother 2010; 65: 2028-36.
34. MARAN-2009. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands. Lelystad, 2011. http://www.lei.wur.nl/NR/rdonlyres/4ED137F2-5A0D-4449-B84E-61A3A8AC4A42/135753/MARAN_2009.pdf (19 September 2011, date last accessed).
35. Nicholls T, Acar J, Anthony F et al. Antimicrobial resistance: monitoring the quantities of antimicrobials used in animal husbandry. Rev Sci Tech 2001; 20: 841-7.
36. van der Fels-Klerx HJ, Puister-Jansen LF, van Asselt ED et al. Farm factors associated with the use of antibiotics in pig production. J Anim Sci 2011; 89: 1922-9.
37. Thrusfield M. Surveys. In: Thrusfield M, ed. Veterinary Epidemiology. Oxford: Blackwell Science, 1996; 178-97.
38. Catry B, Dewulf J, Opsomer G et al. Antimicrobial Use and Resistance in Cattle - Development of a Surveillance System at Herd Level. Brussels: Belgian Federal Public Service for Health, Food Chain Safety, and Environment, 2007.
39. Callens B, Persoons D, Maes D et al. Group level antimicrobial use in Belgian fattening pig herds. In: Abstracts of the Fourth Symposium on Antimicrobial Resistance in Animals and the Environment, Tours-Vinci, 2011. Abstract 021, p. 49. INRA, Tours, France.
40. Cusack PM, McMeniman N, Lean IJ. The medicine and epidemiology of bovine respiratory disease in feedlots. Aust Vet J 2003; 81: 480-7.
41. Taylor JD, Fulton RW, Lehenbauer TWet al. The epidemiology of bovine respiratory disease: what is the evidence for predisposing factors? Can Vet J 2010; 51: 1095-102.
42. WHO. Critically Important Antimicrobials for Human Medicine: Categorization for the Development of Risk Management Strategies to Contain Antimicrobial Resistance due to Non-Human Antimicrobial Use. Report of the Second WHO Expert Meeting, Copenhagen, Denmark, 2007.
43. Green AL, Carpenter LR, Edmisson DE et al. Producer attitudes and practices related to antimicrobial use in beef cattle in Tennessee. J Am Vet Med Assoc 2010; 237: 1292-8.
44. Pardon B, De Bleecker K, Dewulf J et al. Prevalence of respiratory pathogens in diseased, non-vaccinated, routinely medicated veal calves. Vet Rec 2011; 169: 278.
45. Van Donkersgoed J. Meta-analysis of field trials of antimicrobial mass medication for prophylaxis of bovine respiratory disease in feedlot cattle. Can Vet J 1992; 33: 786-95.
46. Booker CW, Abutarbush SM, Schunicht OC et al. Evaluation of the efficacy of tulathromycin as a metaphylactic antimicrobial in feedlot calves. Vet Ther 2007; 8: 183-200.
47. Baggott D, Casartelli A, Fraisse Fet al. Demonstration of themetaphylactic use of gamithromycin against bacterial pathogens associated with bovine respiratory disease in a multicentre farm trial. Vet Rec 2011; 168: 241.
48. Catry B, Duchateau L, Van de Ven J et al. Efficacy of metaphylactic florfenicol therapy during natural outbreaks of bovine respiratory disease. J Vet Pharmacol Ther 2008; 31: 479-87.
49. Sweiger SH, Nichols MD. Control methods for bovine respiratory disease in stocker cattle. Vet Clin North Am Food Anim Pract 2010; 26: 261-71.
50. Bednarek D, Zdzisinska B, Kondracki M et al. Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia. Vet Microbiol 2003; 96: 53-67.
51. Bednarek D, Zdzisinska B, Kondracki M et al. A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffering from enzootic bronchopneumonia. Pol J Vet Sci 2003; 6: 109-15.
52. Yeomans ND, Hawkey CJ, Brailsford W et al. Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs. Curr Med Res Opin 2009; 25: 2785-93.
53. Bardou M, Barkun AN. Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention. Joint Bone Spine 2010; 77: 6-12.
54. DeVincent SJ, Reid-Smith R. Stakeholder position paper: companion animal veterinarian. Prev Vet Med 2006; 73: 181-9.